• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RETRACTABLE TECHNOLOGIES, INC. VANISHING POINT; TUBERCULIN SYRINGE, 1 ML, 25G, 5/8" NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RETRACTABLE TECHNOLOGIES, INC. VANISHING POINT; TUBERCULIN SYRINGE, 1 ML, 25G, 5/8" NEEDLE Back to Search Results
Catalog Number 61370310150
Device Problems Fluid/Blood Leak (1250); Physical Resistance (2578); Device Operates Differently Than Expected (2913)
Patient Problem Underdose (2542)
Event Date 06/03/2015
Event Type  malfunction  
Event Description
When trying to administer 1 cc solution of 0.35 cc methylprednisolone 40 mg/ml with 0.65 cc lidocaine 2% using a vanishing point tuberculin syringe, there was plunger resistance.Only 0.5 cc of solution was administered when the needle retracted and the rest of the medication spilled.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VANISHING POINT
Type of Device
TUBERCULIN SYRINGE, 1 ML, 25G, 5/8" NEEDLE
Manufacturer (Section D)
RETRACTABLE TECHNOLOGIES, INC.
little elm TX 75068
MDR Report Key4834768
MDR Text Key22066217
Report NumberMW5042998
Device Sequence Number1
Product Code FMF
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Physician
Type of Report Initial
Report Date 06/03/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2018
Device Catalogue Number61370310150
Device Lot NumberG131004
Other Device ID Number6 13703 10150 1
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
Treatment
NEURONTIN 300 MG PO AM; CELEBREX 200 MG PO QD; NEURONTIN 600 MG PO HS
Patient Age57 YR
Patient Weight94
-
-